dr. topalian on biomarkers for anti- pd-1 therapies in melanoma
Published 9 years ago • 257 plays • Length 1:43Download video MP4
Download video MP3
Similar videos
-
1:16
dr. suzanne l. topalian on pd-l1 and emerging biomarkers for immunotherapy
-
1:08
dr. suzanne l. topalian on immunotherapy biomarkers in crc
-
1:02
dr. topalian on evolution of pd-1/pd-l1 agents in oncology
-
1:19
dr. hamid on using biomarkers for immunotherapy in melanoma
-
1:27
dr. suzanne topalian on the pd-1 targeted therapy bms-936558
-
16:15
questions & answers with drs. topalian and wolchok about immunotherapy for melanoma
-
0:53
dr. suzanne topalian on the targeted pd-1 immunotherapy bms-936558
-
1:09
dr. topalian on checkmate-358 for gynecologic malignancies
-
1:13
dr. saenger on biomarkers for immunotherapy
-
9:55
suzanne topalian: anti-pd-1 (bms-936558, mdx-1106) in advanced solid tumors
-
34:37
immunotherapy - pd-1 and beyond - melanoma education symposium, patrick ott md phd
-
4:29
anti–pd-1 therapy in metastatic melanoma
-
7:48
the current understanding of biomarkers in melanoma
-
1:15
dr. hamid on tmb as a biomarker for immunotherapy response in melanoma
-
11:16
immunotherapy for melanoma, pt. 2: immune checkpoints & the drugs that block them
-
36:45
symposium - suzanne topalian: harnessing the immune system to treat cancer
-
13:06
immunotherapy for melanoma, pt. 1: an overview
-
5:16
promising biomarkers to select patients for checkpoint inhibitor therapy in melanoma
-
2:24
exploring the impact of anti-pd-1 and anti-pd-l1 agents in merkel cell carcinoma